Trellis Advisors’s Pfizer PFE Stock Holding History

Trellis Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,616	Closed	-$206K	–	91
2023 Q2	$206K	Buy	5,616 +364	+7%	+$14.2K	0.09%	88
2023 Q1	$214K	Sell	5,252 -602	-10%	-$26K	0.1%	80
2022 Q4	$300K	Sell	5,854 -1,557	-21%	-$74.6K	0.16%	64
2022 Q3	$324K	Buy	7,411 +39	+0.5%	+$1.9K	0.18%	50
2022 Q2	$386K	Buy	7,372 +377	+5%	+$19.2K	0.21%	48
2022 Q1	$362K	Buy	6,995 +37	+0.5%	+$1.92K	0.18%	55
2021 Q4	$411K	Sell	6,958 -202	-3%	-$10K	0.19%	50
2021 Q3	$308K	Buy	7,160 +1	+0%	+$44	0.16%	57
2021 Q2	$280K	Buy	7,159 +4	+0.1%	+$156	0.15%	65
2021 Q1	$260K	Sell	7,155 -30	-0.4%	-$1.06K	0.15%	65
2020 Q4	$265K	Buy	+7,185	New	+$264K	0.16%	63
2019 Q3	–	Sell	-5,332	Closed	-$219K	–	52
2019 Q2	$219K	Buy	+5,332	New	+$212K	0.19%	46
2019 Q1	–	Sell	-4,812	Closed	-$200K	–	46
2018 Q4	$200K	Sell	4,812 -34	-0.7%	-$1.41K	0.2%	42
2018 Q3	$203K	Buy	+4,846	New	+$187K	0.18%	47
2018 Q2	–	Sell	-5,957	Closed	-$200K	–	49
2018 Q1	$200K	Buy	+5,957	New	+$205K	0.19%	43

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Trellis Advisors's PFE Position: Q3 2023 in Review

Trellis Advisors sold out of Pfizer (PFE) in Q3 2023, closing a stake of 5,616 shares — an estimated $206K sold.

Trellis Advisors first reported a position in PFE in Q1 2018 and held it in 15 quarters. The position peaked at $411K in Q4 2021. 2,926 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

Trellis Advisors reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
Trellis Advisors sold 5,616 Pfizer shares in Q3 2023, an estimated $206K.
Trellis Advisors first reported a position in Pfizer in Q1 2018 and held it in 15 quarters.
Trellis Advisors's Pfizer position peaked at $411K in Q4 2021.
2,926 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Trellis Advisors's 13F filing for Q3 2023, filed 23 Oct 2023.